A nocturnal temperature controlled laminar flow device (TLA) maintains good control of severe allergic asthma (SAA) after withdrawal of Omalizumab therapy

C. Wang (Taoyuan, Taiwan), C. Lo (Taoyuan, Taiwan), H. Kuo (Taoyuan, Taiwan)

Source: International Congress 2018 – Asthma management
Session: Asthma management
Session type: Poster Discussion
Number: 1694
Disease area: Airway diseases

Congress or journal article abstractSlide presentationWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Wang (Taoyuan, Taiwan), C. Lo (Taoyuan, Taiwan), H. Kuo (Taoyuan, Taiwan). A nocturnal temperature controlled laminar flow device (TLA) maintains good control of severe allergic asthma (SAA) after withdrawal of Omalizumab therapy. 1694

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: